Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-11

Clinical Trial Update: Studies of Dermatologic Diseases Biospecimen Acquisition Protocol

View source ↗

Summary

NIAMS is conducting a biospecimen acquisition protocol study for dermatologic diseases, currently recruiting dermatologic patients, healthy volunteers, and Merk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Conditions: Dermatologic Conditions, Healthy Volunteers | Status: RECRUITING